The ways of improving in the treatment of uterine sarcomas
https://doi.org/10.18027/2224-5057-2017-1-47-50
Abstract
The choice of of ef ficient treatment of uterine sarcomas is challenge, due to the high malignancy and aggressiveness of the tumor, on the one hand, and the lack of a suf ficient amount for the treatment of uterine sarcomas studies on the other. The authors have shown to be promising, and the importance of choosing an adequate level of surgical
treatment and the selectivity in the choice of additional methods of complex treatment. The ar ticle presents the results of treatment of sarcomas of the uterine body cancer (gynecologic) Department of Regional Oncology Center.
treatment and the selectivity in the choice of additional methods of complex treatment. The ar ticle presents the results of treatment of sarcomas of the uterine body cancer (gynecologic) Department of Regional Oncology Center.
About the Authors
D. S. OGAY
IMST MSU
Russian Federation
MD, Ph, DSc, professor, the head of the department of obstetrics and gynecology
Russian Federation
MD, Ph, DSc, professor, the head of the department of obstetrics and gynecology
D. M. VILKOVA
IMST MSU
Russian Federation
MD, PhD, the manager of a teaching department of department of obstetrics and gynecology
Russian Federation
MD, PhD, the manager of a teaching department of department of obstetrics and gynecology
L. N. USTINOVA
No. 4 of GBUZ MO MOOD
Russian Federation
oncologist, the employee of office of an onkoginekologiya
Russian Federation
oncologist, the employee of office of an onkoginekologiya
A. A. KROTENKO
IMST MSU
Russian Federation
MD, PhD, the associate professor of obstetrics and gynecology
Russian Federation
MD, PhD, the associate professor of obstetrics and gynecology
References
1. Аксель Е. М. Статистика злокачественных новообразований женской половой сферы // Онкогинекология. – 2012. – № 1. – С. 18–25.
2. Бохман Я. В., Урманчеева А. Ф. Саркомы матки (монография). – СПб, Гиппократ. – 1996. – 128 с.
3. Завольская Ж. А., Кузнецов В. В., Лазарева Н. И., Кедрова А. Г., Захарова Т. И., Гагуа И. Р. Факторы прогноза и тактика лечения больных эндометриальными стромальными саркомами матки // Сибирский онкологический журнал. № 3–2008, с. 16–20.
4. Климашевский В. Ф., Туркевич Е. А. Морфологическая классификация сарком тела матки // Практическая онкология Т. 9, № 3–2008, с. 125–131.
5. Огай Д. С., Забелин М. В., Черепанова Е. В. Саркома юинга матки: клиническое наблюдение. //Онкогинекология. № 4–2014, с. 34–36.
6. Ульрих Е. А. Особенности лечения сарком матки // Практическая онкология Т. 14, № 2–2013, с. 127–134.
7. Урманчеева А. Ф., Ульрих Е. А. Принципы лечения сарком матки // Практическая онкология Т. 9, № 3–2008, с. 132–136.
8. Швачко С. А., Петерсон С. Б., Грицай А. Н., Лазарева Н. И., Кузнецов В. В. Редкие типы сарком женских половых органов (обзор литературы) // Проблемы репродукции № 6–2009, с. 77–82.
9. FIGO Committee on Gynecologic Oncology. FIGO staging for uterine sarcomas // J. Gynaecol. Obstet. – 2009. – Vol.104. – P. 179.
10. Livi L., Paiar F., Shah N., Blake P., Villanucci A., Amunni G.: Uterine sarcoma: twenty-seven years of experience. Int J Radiat Oncol, Biol, Phys 2003, 57:1366–1373.
11. NCCN Clinical Practice Guidelines in Oncology: uterine neoplasms, Version 1.2014.
12. Sampath S., Schultheiss T. E., Ryu J. K. et al. The role of adjuvant radiation in uterine sarcomas // J. Radiat. Oncol. Biol. Phys. – 2010. – Vol.76. – P. 728–734.
13. Spano J. P., Soria J. C., Kambouchner M., Piperno-Neuman S., Morin F., Morere J. F., Martin A., Breau J. L.: Long term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 2003, 20:87–93.
Review
For citations:
OGAY D.S., VILKOVA D.M., USTINOVA L.N., KROTENKO A.A. The ways of improving in the treatment of uterine sarcomas. Malignant tumours. 2017;(1):47-50. (In Russ.) https://doi.org/10.18027/2224-5057-2017-1-47-50
Views:
790
Email this article 